| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.43 | 0.001 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.39 | 0.009 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.36 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 4e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 6e-09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |